|
MUS81 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.196400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.802000E-01 |
| Normal-vs-Stage2 |
2.779000E-01 |
| Normal-vs-Stage3 |
4.436000E-01 |
| Normal-vs-Stage4 |
7.681600E-01 |
| Stage1-vs-Stage2 |
6.294000E-01 |
| Stage1-vs-Stage3 |
9.088200E-01 |
| Stage1-vs-Stage4 |
7.987600E-01 |
| Stage2-vs-Stage3 |
7.724400E-01 |
| Stage2-vs-Stage4 |
6.118800E-01 |
| Stage3-vs-Stage4 |
7.864400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.253400E-01 |
| Normal-vs-AfricanAmerican |
2.266400E-01 |
| Normal-vs-Asian |
6.044200E-01 |
| Caucasian-vs-AfricanAmerican |
9.391000E-01 |
| Caucasian-vs-Asian |
3.099400E-01 |
| AfricanAmerican-vs-Asian |
2.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.725200E-01 |
| Normal-vs-Female |
1.576370E-01 |
| Male-vs-Female |
4.599000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.369400E-01 |
| Normal-vs-Extreme_Weight |
2.392000E-01 |
| Normal-vs-Obese |
2.192200E-01 |
| Normal-vs-Extreme_Obese |
3.993000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.605000E-01 |
| Normal_Weight-vs-Obese |
9.880200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.223000E-01 |
| Extreme_Weight-vs-Obese |
8.324000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.868200E-01 |
| Obese-vs-Extreme_Obese |
9.159200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.429800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.330000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.355000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.786000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.172200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.438500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.205800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.063900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.281700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.825700E-02 |
| Normal-VS-Type2 PRCC |
1.161010E-01 |
| Normal-VS-KIRP CIMP |
8.622200E-02 |
| Normal-VS-Unclassified PRCC |
4.530200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.12369999866391E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.044200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.420160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.798900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.359520E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.229800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.371600E-01 |
| Normal-vs-N1 |
2.868800E-01 |
| Normal-vs-N2 |
9.996300E-02 |
| N0-vs-N1 |
3.755800E-01 |
| N0-vs-N2 |
7.459600E-02 |
| N1-vs-N2 |
6.781800E-02 |
|
|
